Scaling Up Point-of-Care Fentanyl Testing - A Step Forward.
作者信息
Barnett Brian S, Chai Peter R, Suzuki Joji
机构信息
From the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland (B.S.B.); and the Departments of Emergency Medicine (P.R.C.) and Psychiatry (J.S.), Brigham and Women's Hospital, the Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute (P.R.C.), and the Fenway Institute (P.R.C.), Boston, and the Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Cambridge (J.S.) - all in Massachusetts.
出版信息
N Engl J Med. 2023 Nov 2;389(18):1643-1645. doi: 10.1056/NEJMp2308525. Epub 2023 Oct 28.
Abstract
摘要
相似文献
1
Scaling Up Point-of-Care Fentanyl Testing - A Step Forward.扩大即时护理芬太尼检测——向前迈进的一步。
N Engl J Med. 2023 Nov 2;389(18):1643-1645. doi: 10.1056/NEJMp2308525. Epub 2023 Oct 28.
2
Detecting fentanyl using point-of-care drug checking technologies: A validation study.使用即时药物检测技术检测芬太尼：一项验证研究。
Drug Alcohol Depend. 2020 Jul 1;212:108006. doi: 10.1016/j.drugalcdep.2020.108006. Epub 2020 May 12.
3
Designing traceable opioid material kits to improve laboratory testing during the U.S. opioid overdose crisis.设计可追踪的阿片类物质试剂盒，以改善美国阿片类药物过量危机期间的实验室检测。
Toxicol Lett. 2019 Dec 15;317:53-58. doi: 10.1016/j.toxlet.2019.09.017. Epub 2019 Sep 24.
4
Killer fentanyl: a lesson from anaesthesiology.
Lancet. 2006 Oct 7;368(9543):1237-8. doi: 10.1016/S0140-6736(06)69516-0.
5
[Validation of a method to inactivate fentanyl in the used devices of Durogesic].
Ann Pharm Fr. 2000 May;58(3):176-9.
6
[Studies on crystal structures and structure-activity relationships of the 4-substituted fentanyl derivatives].
Yao Xue Xue Bao. 1987 Nov;22(11):864-8.
7
Ten Years of Fentanyl-like Drugs: a Technical-analytical Review.十年类芬太尼药物：技术分析综述
Anal Sci. 2019 May 10;35(5):479-491. doi: 10.2116/analsci.18R004. Epub 2019 Jan 25.
8
Drug checking as a potential strategic overdose response in the fentanyl era.药物检测作为芬太尼时代潜在的战略过量应对措施。
Int J Drug Policy. 2018 Dec;62:59-66. doi: 10.1016/j.drugpo.2018.10.001. Epub 2018 Oct 22.
9
Commentary. Fentanyl-related death and the underreporting risk.评论。芬太尼相关死亡及漏报风险。
J Forensic Leg Med. 2018 Nov;60:35-37. doi: 10.1016/j.jflm.2018.09.007. Epub 2018 Sep 21.
10
The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl "disguised" as other opioids.乙酰芬太尼的潜在威胁：法律问题、受污染的海洛因以及伪装成其他阿片类药物的乙酰芬太尼。
Ann Emerg Med. 2014 Dec;64(6):637-9. doi: 10.1016/j.annemergmed.2014.07.017. Epub 2014 Aug 18.
引用本文的文献
1
An implantable system for opioid safety.一种用于阿片类药物安全的可植入系统。
Device. 2024 Oct 18;2(10). doi: 10.1016/j.device.2024.100517. Epub 2024 Aug 14.
2
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl.美沙酮预处理戒断的芬太尼住院患者。
JAMA Netw Open. 2024 Sep 3;7(9):e2435895. doi: 10.1001/jamanetworkopen.2024.35895.
3
Artificial Intelligence in Point-of-Care Biosensing: Challenges and Opportunities.即时护理生物传感中的人工智能：挑战与机遇
Diagnostics (Basel). 2024 May 25;14(11):1100. doi: 10.3390/diagnostics14111100.
本文引用的文献
1
Protracted renal clearance of fentanyl in persons with opioid use disorder.阿片类物质使用障碍者中芬太尼的肾脏清除时间延长。
Drug Alcohol Depend. 2020 Sep 1;214:108147. doi: 10.1016/j.drugalcdep.2020.108147. Epub 2020 Jul 2.
2
An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.三种用于公共卫生的街头缴获样本中芬太尼药物检测的设备的检测限、灵敏度和特异性评估。
Int J Drug Policy. 2020 Mar;77:102661. doi: 10.1016/j.drugpo.2020.102661. Epub 2020 Jan 14.
3
Evidence of fentanyl use is common and frequently missed in a cross-sectional study of emergency department patients in Baltimore, Maryland.在马里兰州巴尔的摩市的一项横断面研究中，急诊患者中常见且经常漏检芬太尼使用的证据。
Clin Toxicol (Phila). 2020 Jan;58(1):59-61. doi: 10.1080/15563650.2019.1605078. Epub 2019 Apr 22.
Zotero 插件